|
Ding WY, Kotalczyk A, Boriani G, Marin F, Blomstrom-Lundqvist C, Potpara TS, Fauchier L, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry. Eur J Intern Med. 2022 Sep;103:41-49. doi: 10.1016/j.ejim.2022.04.026. Epub 2022 May 6. PubMed PMID: 35527179.
AÑO: 2022; IF: 8.0
|
35527179
|
Marin F, Fernandez MS, Lekuona I, Arribas F, Baron-Esquivias G, Barrios V, Cosin-Sales J, Freixa-Pamias R, Masjuan J, Perez-Cabeza AI, Schilling VR, Vazquez Rodriguez JM, Priu CR, Sanchez MA. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries. J Comp Eff Res. 2022 Nov;11(16):1173-1184. doi: 10.2217/cer-2022-0111. Epub 2022 Sep 23. PubMed PMID: 36148923.
AÑO: 2022; IF: 2.1
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Sanmartin Fernandez M, Arribas F, Masjuan J, Barrios V, Cosin-Sales J, Freixa-Pamias R, Recalde E, Perez-Cabeza AI, Manuel Vazquez Rodriguez J, Rafols Priu C, Anguita Sanchez M, Lip GYH, Marin F. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):38-46. doi: 10.1093/ehjcvp/pvac060. PubMed PMID: 36318457.
AÑO: 2022; IF: 7.1
|
|
Esteve-Pastor MA, Ruiz-Ortiz M, Muniz J, Roldan-Rabadan I, Otero D, Cequier A, Bertomeu-Martinez V, Badimon L, Anguita M, Lip GYH, Marin F. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry. Front Cardiovasc Med. 2022 May 2;9:856222. doi: 10.3389/fcvm.2022.856222. eCollection 2022. PubMed PMID: 35586656; PubMed Central PMCID: PMC9108173.
AÑO: 2022; IF: 3.6
|
|
Anguita Sanchez M, Marin F, Masjuan J, Cosin-Sales J, Vazquez Rodriguez JM, Barrios V, Baron-Esquivias G, Lekuona I, Perez-Cabeza AI, Freixa-Pamias R, Parra Jimenez FJ, Monzer Khanji Khatib M, Rafols Priu C, Sanmartin Fernandez M. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study. Cardiol J. 2022;29(6):936-947. doi: 10.5603/CJ.a2022.0091. Epub 2022 Oct 6. PubMed PMID: 36200548; PubMed Central PMCID: PMC9788750.
AÑO: 2022; IF: 2.9
|